Definitive Healthcare annual stock-based compensation
2020
2021
2022
2023
2024
2025
Definitive Healthcare Stock-Based Compensation Growth & History (DH)
Definitive Healthcare's stock-based compensation was $29.1M for fiscal 2025.
View full Definitive Healthcare company overviewDefinitive Healthcare annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $29.1M | −$8.9M | −23.48% |
| 2024 | 2024-12-31 | $38.1M | −$10.7M | −21.86% |
| 2023 | 2023-12-31 | $48.7M | $12.3M | +33.77% |
| 2022 | 2022-12-31 | $36.4M | $26.5M | +265.91% |
| 2021 | 2021-12-31 | $10.0M | $8.2M | +469.95% |
| 2020 | 2020-12-31 | $1.7M | — | — |
Definitive Healthcare quarterly stock-based compensation
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.3M | −$1.7M | −24.73% |
| Q1 2026 | 2026-03-31 | $5.2M | −$2.1M | −28.68% |
| Q4 2025 | 2025-12-31 | $8.2M | $796,000 | +10.81% |
| Q3 2025 | 2025-09-30 | $6.7M | $388,000 | +6.16% |
| Q2 2025 | 2025-06-30 | $7.0M | −$1.9M | −21.06% |
| Q1 2025 | 2025-03-31 | $7.3M | −$8.3M | −53.03% |
| Q4 2024 | 2024-12-31 | $7.4M | −$5.9M | −44.43% |
| Q3 2024 | 2024-09-30 | $6.3M | −$5.7M | −47.51% |
| Q2 2024 | 2024-06-30 | $8.8M | −$3.5M | −28.48% |
| Q1 2024 | 2024-03-31 | $15.6M | $4.5M | +40.03% |
| Q4 2023 | 2023-12-31 | $13.3M | $1.8M | +16.02% |
| Q3 2023 | 2023-09-30 | $12.0M | $2.9M | +31.33% |
| Q2 2023 | 2023-06-30 | $12.4M | $3.4M | +37.29% |
| Q1 2023 | 2023-03-31 | $11.1M | $4.3M | +61.93% |
| Q4 2022 | 2022-12-31 | $11.4M | $5.8M | +103.31% |
| Q3 2022 | 2022-09-30 | $9.1M | $6.8M | +294.17% |
| Q2 2022 | 2022-06-30 | $9.0M | $7.4M | +457.59% |
| Q1 2022 | 2022-03-31 | $6.9M | $6.5M | +1592.61% |
| Q4 2021 | 2021-12-31 | $5.6M | — | — |
| Q3 2021 | 2021-09-30 | $2.3M | $1.9M | +405.90% |
| Q2 2021 | 2021-06-30 | $1.6M | — | — |
| Q1 2021 | 2021-03-31 | $406,000 | — | — |
| Q3 2020 | 2020-09-30 | $458,000 | — | — |
Definitive Healthcare stock-based compensation trends
Over the last five fiscal years, Definitive Healthcare's stock-based compensation increased from $1.7M to $29.1M, a change of $27.4M. The latest reported quarter, Q2 2026, shows $5.3M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Definitive Healthcare source filings ↗